4th Quarter - Report
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC) for ASTELLAS PHARMA US, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
- The Federal, Food, Drug and Cosmetic Act - The Food and Drug Administration Safety and Innovation Act (FDASIA) - Bayh-Dole Act/ march in authority
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Medicare/Medicaid MMM
- CMMI Part B Drug Payment Demonstration Program - General reimbursement issues - H.R. 1178- Ensuring Equal Access to Treatments Act- all provisions
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEVEN E IRIZARRY | — |
| VINCENT A. ROBERTI, SR. | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.